About STAQ Pharma
STAQ Pharma is a private company based in Denver, Colorado. It has reported $61,409,507 raised in six offerings on Form D since November 2017. Its chief executive is Joseph Bagan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2024 | Sep 16, 2024 | $11,400,001of $30.0M target | 8 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Apr 17, 2023 | Apr 28, 2023amended Jun 21, 2023 | $10,121,691of $20.0M target | 17 | $595K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 21, 2020 | Jan 5, 2021amended Dec 23, 2021 | $30,262,815of $60.0M target | 19 | $1.5M | Equity, DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 22, 2019 | May 3, 2019amended Mar 31, 2021 | $9,000,000fully sold | 23 | $391K | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Not yet | Apr 3, 2018 | $0of $3.5M target | 0 | — | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 31, 2017 | Nov 21, 2017 | $625,000fully sold | 2 | $312K | EquityRule 506(c) | Form D ↗ |
| Total, six offerings | $61,409,507 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on STAQ Pharma's Form D filed Sep 16, 2024.
SH
Scott Hawig
Director
MS
Mark Spiecker
Executive officer and director
CL
Carol Lewis
Director
CK
Chet Kaczor
Director
DS
Dan Seff
Director
BH
Brad Hauert
Director
JB
Joseph Bagan
Chief Executive Officer and director
JH
Jeffrey Hval
Executive officer and director
PJ
Paul Jenny
Director
Earlier filings also listed Jerrod Milton (director, last listed Jun 2023), Abram Gordon (director, last listed Jun 2023), Steven Summer (director, last listed Dec 2021), Stephen Davis (director, last listed Mar 2021) and Donna Lynne (director, last listed Mar 2021).